By Millie Harry
We’re excited to share the successful installation of Horizon 3.0 at Bowmere Hospital, Countess of Chester Health Park, UK, part of the Cheshire and Wirral Partnership NHS Foundation Trust. A big thank you to Jamie Robertson and Derin Rose for their excellent work on the installation, and to David Wilkinson for ensuring everything went smoothly … Continued
By Millie Harry
Magstim is excited to announce our participation in this year’s BrainStim conference, taking place in the vibrant and dynamic setting of Japan. As a global leader in transcranial magnetic stimulation (TMS) and neurotechnology solutions, we’re thrilled to connect with the brightest minds in neuroscience and mental health research. Visit Us at Booth 17-18 Find us … Continued
By Millie Harry
Last month, Magstim attended the Royal College of Psychiatrists conference, where Neuromodulation Techniques, particularly Transcranial Magnetic Stimulation (TMS), took center stage. A key highlight was Professor Richard Morris’ presentation on the BRIGhTMIND study, which demonstrated the effectiveness of TMS as a first-line treatment over Electroconvulsive Therapy (ECT). With positive results and a milder side effect … Continued
By Millie Harry
Karen Wendt, Magstim EGI European Sales Manager attended the Society for Psychophysiological Research (SPR) Conference in Prague last week. The event kicked off with a Welcome Reception on Wednesday evening, where attendees had an introduction to the first Poster Session. The following days were filled with symposia, posters, and plenaries covering a broad range of … Continued
By Millie Harry
We are excited to announce that Magstim attended the Society for Neuroscience (SFN) 2024 conference! SFN is the premier event for neuroscience professionals, and this year we had the opportunity to showcase our latest innovations to study and treat the brain with non-invasive neuromodulation. We demonstrated our advanced transcranial magnetic stimulation (TMS) systems, which … Continued